HIV-1 compartmentalization in the central nervous system during cryptococcal meningitis: Analysis of viral, fungal, and host factors
Opportunistic infections in the central nervous system (CNS), such as cryptococcal meningitis (CM) have profound consequences for people living with HIV-1 (PWH), including blood-brain barrier impairment and neuroinflammation. To investigate how CM may shape the HIV-1 populations in the CNS, we characterized viral variants in the blood and cerebrospinal fluid (CSF) compartments in PWH with active CM. Thirty-nine participants with CM had paired plasma and CSF viral load measurements prior to the start of anti-retroviral therapy (pre-ART), with overall significantly higher HIV-1 viral loads in plasma compared to the CSF. Among those with CSF pleocytosis, CSF viral loads were relatively higher and CCR5 coreceptor-utilizing HIV-1 were more frequently detected. To investigate whether these differences were due to sustained HIV-1 replication in the CNS that generated genetically distinct viral lineages in the CSF (i.e., viral compartmentalization), we characterized pre-ART HIV-1 env populations in a subgroup of eighteen PWH with CSF HIV-1 RNA levels > blood (N = 9) and CSF RNA levels < blood (N = 9). Compartmentalization between CSF and plasma viral populations was detected in participants from both groups and was associated with higher interleukin-2 (IL-2) levels in CSF. In some cases, HIV-1 populations in CSF were compartmentalized from plasma, were exclusively macrophage-tropic and reached levels exceeding 105 copies/ml CSF. In other cases, HIV-1 infected cells trafficking across the plasma and CSF compartments seemed the most likely source of virus in the CSF. Post-ART analysis in one participant demonstrated emergence of distinct HIV-1 populations. This study demonstrates that opportunistic infections may have diverse effects in shaping HIV-1 viral populations.
Authors
- Christine M. Fennessey (ORCID: https://orcid.org/0000-0002-8736-8523)
- Natalie Lindo
- Kristi Huik (ORCID: https://orcid.org/0000-0002-1569-8830)
- David R. Boulware (ORCID: https://orcid.org/0000-0002-4715-0060)
- Christian Gonsalves
- Matthew Moeser (ORCID: https://orcid.org/0000-0002-1368-5171)
- Sarah Joseph (ORCID: https://orcid.org/0000-0001-9603-574X)
- Brandon F. Keele (ORCID: https://orcid.org/0000-0002-2381-1151)
- Maura M. Manion (ORCID: https://orcid.org/0000-0003-0991-0011)
- David B. Meya (ORCID: https://orcid.org/0000-0002-8854-0321)
- James Q. Virga (ORCID: https://orcid.org/0000-0003-2539-4029)
- Frank M. Maldarelli (ORCID: https://orcid.org/0000-0002-3062-5250)
- Camille Lange (ORCID: https://orcid.org/0000-0003-2666-7850)
- Ana Maria Ortega‐Villa (ORCID: https://orcid.org/0000-0002-5589-9557)
- Irini Sereti (ORCID: https://orcid.org/0000-0002-0076-0224)
- Helene Highbarger
Institutions
- University of Minnesota (US)
- Frederick National Laboratory for Cancer Research (US)
- National Institute of Allergy and Infectious Diseases (US)
- Makerere University (UG)
Publication Details
- Journal
- PLoS Pathogens
- Published
- 2026-10-15
- DOI
- https://doi.org/10.1371/journal.ppat.1014697
- Primary Topic
- HIV Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Health and Human Services
- National Institutes of Health
- National Cancer Institute